Canadian Stock Exchange Agn Cn News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Canadian stock exchange agn cn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Canadian Stock Exchange Agn Cn Today - Breaking & Trending Today

Algernon NeuroScience and the Centre for Human Drug

VANCOUVER, British Columbia, April 24, 2024 (GLOBE NEWSWIRE) Algernon Pharmaceuticals Inc. (the “Company” or “AGN Pharma”) (CSE: AGN) (FRANKFURT:. ....

Noord Holland , United Kingdom , British Columbia , Christopherj Moreau , Rick Strassman , Algernon Pharmaceuticals Inc , Constraint Induced Movement Therapy , Algernon Pharmaceuticals , Centre For Human Drug Research , Seyltx Inc , Interdisciplinary Conference On Psychedelic Research , Company Phase , Algernon Neuroscience , Human Drug Research , Interdisciplinary Conference , Psychedelic Research , Katelijne Van , Spirit Molecule , Brain Derived Neurotrophic Factor , Constraint Induced Movement , Stroke Study , Canadian Stock Exchange Agn Cn , Algernon Pharmaceuticals Inc , Phase 1 , Algernon Neuroscience ,

Algernon Pharmaceuticals Announces 4 for 1 Forward Share

VANCOUVER, British Columbia, Feb. 28, 2023 (GLOBE NEWSWIRE) Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or. ....

United Kingdom , British Columbia , Christopherj Moreau , Trust Company , Algernon Pharmaceuticals , Company Or Algernon , Algernon Pharmaceuticals Inc , Shareholders Of The Company Do , Common Shares , Common Share , Forward Split , Algernon Neuroscience , Canadian Stock Exchange Agn Cn , Algernon Pharmaceuticals ,

Algernon Pharmaceuticals Announces Plans for a 180 Patient

Ifenprodil Represents a Novel First-in-Class Potential Treatment for Chronic Cough. ....

United States , United Kingdom , British Columbia , Christopherj Moreau , Jacky Smith , Company Phase , Honorary Consultant At Manchester University , Algernon Pharmaceuticals , University Of Manchester , Drug Administration , Merck Co , Algernon Pharmaceuticals Inc , Afferent Pharmaceuticals , Bellus Health , While The Company , Market Research , Respiratory Medicine , Honorary Consultant , Manchester University , Idiopathic Pulmonary Fibrosis , Investigational New Drug , Data Bridge Market Research , Algernon Neuroscience , Canadian Stock Exchange Agn Cn , Algernon Pharmaceuticals ,

Algernon Pharmaceuticals Enters into a Clinical Trial

VANCOUVER, British Columbia, Oct. 24, 2022 (GLOBE NEWSWIRE) Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0). ....

United States , United Kingdom , Yale School , British Columbia , Christopherj Moreau , Deepak Cyril Dsouza , Deepak Dsouza , Yale University , Yale School Of Medicine , Algernon Pharmaceuticals , Algernon Pharmaceuticals Inc , Yale University School Of Medicine , Company Or Algernon , Schizophrenia Neuropharmacology Research Group , Investigator Initiated Clinical Trial Agreement , Professor Deepak Cyrild Souza , United States Government , Deepakd Souza , Yale University School , Canadian Stock Exchange Agn Cn , Algernon Pharmaceuticals , Phase 2 , Linical Triial ,

Algernon Pharmaceuticals Hits Co-Primary Endpoint in its

VANCOUVER, British Columbia, July 18, 2022 (GLOBE NEWSWIRE) Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT:. ....

United Kingdom , British Columbia , Christopherj Moreau , Martin Kolb , Jacky Smith , Airway Fibrosis , Mcmaster University , International Colloquium On Lung , Honorary Consultant At Manchester University , University Of Manchester , Company Or Algernon , Algernon Pharmaceuticals Inc , Respiratory Medicine , Honorary Consultant , Manchester University , International Colloquium , Canadian Stock Exchange Agn Cn , Algernon Pharmaceuticals , Chronic Cough , Phase 2 ,